Trade CVS Health - CVS CFD

Market is not available at the momentMarket information is presented
as of 2026-10-16T20:45:44+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.79
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.02224 %
(-$4.45)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.02224%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
0.00001 %
($0.00)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


0.00001%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity0.1
Margin5.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close91.8
Open91.8
1-Year Change13.75%
Day's Range91.8 - 93.14

Trade CVS Health - CVS

CVS Health (CVS) is an American health service provider headquartered in Woonsocket, Rhode Island. 

In 1963, brothers Stanley and Sidney Goldstein, and Ralph Hoagland founded the company in Lowell, Massachusetts. The first CVS store sold health and beauty products. CVS stands for Consumer Value Stores.

CVS Health has four business segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other.

The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, MedicareAdvantage and health information. The segment serves around 35 million customers, including employer groups, individuals, college students, part-time and hourly workers, health care providers, government-sponsored plans, labour groups and expatriates.

The Pharmacy Services segment provides pharmacy benefit management (PBM) solutions, including, plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, clinical services and disease management services. The segment’s customers include employers, insurance companies, unions, government employee groups, health plans, plans offered on insurance exchanges and other sponsors of health benefit plans.

The Retail/LTC segment sells prescription drugs, health and wellness products, and general merchandise. It also provides health care services through its MinuteClinic walk-in medical clinics, medical diagnostic testing, and administers vaccinations for illnesses such as influenza and Covid-19. 

Long-term care pharmacy operations are also part of the segment. They distribute prescription pharmaceuticals as well as provide pharmacy consulting and other ancillary services to care homes and other care settings.

As of 31 December 2021, the Retail/LTC segment operated more than 9,900 locations, nearly 1,200 MinuteClinic locations, online services, LTC pharmacies and on-site pharmacies. CVS Health announced in November 2021 that it plans to close 900 stores in the next three years as part of its strategy to overhaul its retail business. The closures will start in spring 2022.

The company dispensed about 26.4% of all retail pharmacy prescriptions in the US in 2021. 

The Corporate/Other segment provides management and administrative expenses to support the Company’s overall operations. It also offers products for which the company no longer solicits or accepts new customers such as large case pensions and long-term care insurance products.

The company’s shares are traded on the New York Stock Exchange under the ticker symbol CVS.

Latest shares articles

BAE Systems stock forecast
BAE Systems stock forecast: H1 results, guidance upgrade
BAE Systems is a UK defence and aerospace group listed in London. In August 2026, it secured a $149.8m US Navy award for work on the USS Boxer. Explore third-party BA. price targets and technical analysis. Past performance is not a reliable indicator of future results.
07:18, 16 October 2026
TAURON stock forecast
TAURON stock forecast: H1 earnings
TAURON is a Polish energy group. In the first half of 2026, revenue was broadly flat, while EBITDA and net profit fell amid higher CO2 allowance costs and coal consumption. Explore third-party analyst targets and technicals. Past performance is not a reliable indicator of future results.
12:04, 12 October 2026
Puma stock forecast
Puma stock forecast: Anta stake deal cleared
Puma is a German sportswear company. Chinese regulators have cleared Anta Sports’ proposed acquisition of an approximately 29% stake, with completion expected before the end of 2026. Explore third-party PUM price targets. Past performance is not a reliable indicator of future results.
10:19, 12 October 2026
Dino Polska stock forecast
Dino Polska stock forecast: H1 sales growth slows
Dino Polska is a Polish grocery retailer. In H1 2026, revenue rose 12.5% year on year to 18.0bn PLN, while like-for-like sales growth slowed to 2.2%. Explore third-party DNP price targets and technical analysis. Past performance is not a reliable indicator of future results.
08:27, 12 October 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready